The biggest deals in pharma don't stall because of the science. They stall because of procurement. Here's what we learned.

The biggest deals in pharma don't stall because of the science. They stall because of procurement. Here's what we learned.

In pharma, data security isn't a formality. A molecule in development could represent billions in future revenue. 

The IP sitting inside a client's optimization campaigns is among the most sensitive data they own. Of course procurement and IT teams are rigorous about who touches it.

Third-party certification isn't about having better security. It's about proving it and in regulated industries, that distinction matters enormously.

One thing that struck us: almost every client security questionnaire asked nearly identical questions. Doing this once - properly and in a structured way - means we can now answer them efficiently and consistently across every future procurement process.

With @ReactWise being ISO 27001 and SOC 2 Type II certified, we expect future enterprise deals to move significantly faster as a result.

If you're building deep tech for regulated industries: don't treat compliance as a box to check later. Treat it as a commercial enabler.

‍